Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,726,881 papers from all fields of science
Search
Sign In
Create Free Account
MNX1-AS1 gene
Known as:
MNX1 antisense RNA 1 (head to head)
, MNX1-AS1
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
Y-X Zhang
,
Haibin Cui
,
L. Liu
,
Guangkun Yi
European Review for Medical and Pharmacological…
2019
Corpus ID: 198998416
OBJECTIVE Recent studies revealed that long non-coding RNAs (lncRNAs) participate in the progression and development of many…
Expand
2019
2019
MNX1-AS1 accelerates the epithelial-mesenchymal transition in osteosarcoma cells by activating MNX1 as a functional oncogene.
WU F.
,
Y. Zhong
,
X-B Lang
,
TU Y.-L.
,
S-F Sun
European Review for Medical and Pharmacological…
2019
Corpus ID: 204866359
OBJECTIVE To investigate whether MNX1-AS1 can accelerate epithelial-mesenchymal transition (EMT) of osteosarcoma cells via…
Expand
2019
2019
Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2.
D-N Zheng
,
C-J Zhang
,
G. Sun
European Review for Medical and Pharmacological…
2019
Corpus ID: 198999232
OBJECTIVE Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor with a high mortality rate and poor prognosis. In…
Expand
2017
2017
Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
A. Li
,
H-H Zhang
European Review for Medical and Pharmacological…
2017
Corpus ID: 9770892
OBJECTIVE Long non-coding RNAs MNX1-AS1(MNX1-AS1) has been proved to be associated with ovarian cancer proliferation and invasion…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE